You are using an outdated browser. Please upgrade your browser to improve your experience.

trelagliptin

Ligand Summary
Ligand Structure
Rendered image for the query structure
Description
Trelagliptin is an orally active dipeptidyl peptidase (DPP)-4 inhibitor developed by Takeda and approved in Japan for the treatment of type 2 diabetes mellitus.
Synonyms & Links
PubChem: 15983988
ChEMBL: CHEMBL1650443
DrugCentral: 5013
LyCHI:  AK17MSZBKLPC


Target Activities